Axial Therapeutics

Developer of small molecule therapeutics for central nervous system disorder

placeWaltham, Massachusetts, United States calendar_todayFounded 2016 groups12 employees language axialtx.com

Registered entities

Social engagement

Social engagement: 4.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include One Ventures, UTokyo Innovation Platform, Longwood Fund, Seventure Partners.

Investor typeCountShare
Venture capital1083%
Other / undisclosed217%

Recent activity

19 May 2026
Milestone
regulatory
7 Jan 2026
Event
J.P. Morgan Healthcare Conference
16 Dec 2025
Leadership hire
Independent Chair of our BoardOfDirectors
Coming soon